| The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. | skin, |
| Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse. | leukemia, |
| probably does not have a role as tumor suppressor in sporadic pilocytic astrocytomas | astrocytomas, |
| Status of the NF1 tumor suppressor locus in uveal melanoma. | skin, |
| Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases. | schwannomas, |
| NF1 tumor suppressor gene is a direct transcriptional target of RUNX1 and the t(8;21) fusion protein, suggesting that suppression of NF1 expression contributes to the molecular pathogenesis of acute myeloid leukemia . | leukemia, |
| Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. | astrocytomas, |
| Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. | glioma, |
| An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. | prostate, |
| NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. | neuroblastoma, |
| NF1 is a key tumor suppressor lost in melanomas. | skin, |
| CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma | skin, |
| Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma | skin, |
| The neurofibromatosis type 1 (NF1) tumor suppressor gene and myeloid leukemia. | leukemia, |
| Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor. | brain, |
| Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. | None |
| Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. | None |
| The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice. | None |
| Neurofibromin, a tumor suppressor in the nervous system. | None |
| Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. | None |